Resignation of Mr. Kartik Kapur, Independent Director of the Company.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kwality Pharmaceuticals has informed BSE about a change in its Board of Directors. Mr. Kartik Kapur (DIN: 08966816) has resigned as Independent Director effective end of business hours on June 02, 2026, citing other professional commitments. He confirmed there are no other material reasons for his exit and holds no directorship in any other listed company. In his place, the Board has appointed Mr. Swanith Kapoor (DIN: 11662482) as Additional (Non-Executive, Independent) Director for a 5-year term from June 02, 2026 to June 01, 2031, subject to shareholder approval. Mr. Swanith Kapoor is a legal professional with a B.B.A. LL.B. (Hons.) specializing in Corporate Law from UPES, Dehradun, and is pursuing a Master's in Business Laws from NLSIU, Bengaluru. He is not related to any existing Director and is not debarred from holding the office of Director by SEBI or any authority.
This is a routine board-level reshuffle — one Independent Director stepping down for personal professional reasons and being replaced by another Independent Director with a legal background. No governance red flags have been raised, and the change is unlikely to materially affect the stock price or shareholder interests.